Amazon, Google, other industry leaders sign off on new healthcare-focused AI standard

The Consumer Technology Association (CTA) has developed a new standard for the use of AI in healthcare, working with representatives from more than 50 organizations impacted by this evolving technology. Participants in the creation of this standard included Amazon, the American Medical Association, AT&T, Google, Humana, IBM, Philips, Verizon and many more.

“This standard creates a firm base for the growing use of AI in our health care—technology that will better diagnose diseases, monitor patients’ recoveries and help us all live healthier lives,” Gary Shapiro, CTA’s president and CEO, said in a prepared statement. “This is a major first step —convening some of the biggest players in the digital health world—to help create a more efficient healthcare system and offer value-based health care to Americans.” 

The standard defines key AI-related terms such as “machine learning,” “model bias,” “artificial neural network,” aiming to ensure that everyone working with this technology shares the same basic understanding of its abilities, effectiveness and potential.

“AI will play a major role in driving efficiency in healthcare and will support clinicians in making more precise diagnosis, offer personalized treatment and better guidance towards improved outcomes,” Pat Baird, regulatory head of global software standards for Philips and co-chair of the working group behind the standard, said in the same statement. “This implies that AI will be used for decision support and decision making, which stresses the need for professionals to be able to take ownership, apply judgment and empathy. Transparency and a common language will be key to enable the proper and safe functioning of AI.”   

The standard is available is full on the CTA website.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.